摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-methoxy-4-androstene-3,17-dione | 20986-46-3

中文名称
——
中文别名
——
英文名称
4-methoxy-4-androstene-3,17-dione
英文别名
4-methoxyandrost-4-ene-3,17-dione;4-methoxyandrostenedione;(8R,9S,10R,13S,14S)-4-methoxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione
4-methoxy-4-androstene-3,17-dione化学式
CAS
20986-46-3
化学式
C20H28O3
mdl
——
分子量
316.441
InChiKey
JYMVNNNTLDUEBG-PFIYWFKMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    23
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:445d01c35cab0a5350caf30111248356
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-methoxy-4-androstene-3,17-dione盐酸 作用下, 以 1,4-二氧六环 为溶剂, 反应 24.0h, 以53%的产率得到福美司坦
    参考文献:
    名称:
    Mann, John; Pietrzak, Barbara, Journal of the Chemical Society. Perkin transactions I, 1983, # 11, p. 2681 - 2685
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    Synthesis and evaluation of a new series of mechanism-based aromatase inhibitors
    摘要:
    A series of new 4-(alkylthio)-substituted androstenedione analogues was designed as potential suicide inhibitors of aromatase on the basis of mechanistic considerations on the mode of action of the enzyme. Their synthesis and biological evaluation are described. Among the most interesting are the 4-[(difluoromethyl)thio]-, 4-[(fluoromethyl) thio]-, and 4-[(chloromethyl)thio]androstenediones 12,13, and 14 with respective IC50's of 2.7,0.8, and 0.94-mu-M. Compound 12 was a reversible inhibitor of aromatase while compounds 13 and 14 displayed time-dependent kinetics of inhibition with respective K(I)'s and half-times of inactivation of 30 nM and 3.75 min for 13 and 30 nM and 3 min for 14. The inhibition of aromatase by 14 was NADPH-dependent, and was protected by the presence of substrate (0.5-1-mu-M), while beta-mercaptoethanol (0.5 mM) failed to protect the enzyme from inactivation. Dialysis failed to reactivate aromatase previously inactivated by 14. The mechanistic implications of these findings are
    DOI:
    10.1021/jm00087a013
点击查看最新优质反应信息

文献信息

  • Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders
    申请人:Wang Changjin
    公开号:US20100087402A1
    公开(公告)日:2010-04-08
    The present invention relates to the treatment of estrogen-dependent hyperproliferative uterine disorders including endometriosis, uterine fibroids, endometrial hyperplasia, uterine cancer, and their related symptoms by intravaginally administering at least two active agents selected from an aromatase inhibitor, an antiinflammatory agent, and a uterine-selective estrogen receptor antagonist. This combination therapy reduces local estrogen production, blocks local estrogen action, and suppresses inflammation locally, resulting in starvation of the estrogen-dependent diseased tissues, relief of related symptoms, and retardation of disease progression. Intravaginal delivery maximizes local inhibition of estrogen production without significantly affecting systemic circulating estrogen levels. This results in enhanced clinical efficacy and reduced side effects.
    本发明涉及治疗依赖雌激素的子宫过度增生性疾病,包括子宫内膜异位症、子宫肌瘤、子宫内膜增生、子宫癌及其相关症状,通过阴道给药至少两种活性药物,所选药物包括芳香化酶抑制剂、抗炎药和子宫选择性雌激素受体拮抗剂。这种联合疗法降低了局部雌激素产生,阻断了局部雌激素作用,并在局部抑制了炎症,导致对依赖雌激素的疾病组织的饥饿,缓解相关症状,延缓疾病进展。阴道给药最大限度地抑制了局部雌激素产生,而不显著影响全身循环雌激素水平。这导致增强的临床疗效和减少的副作用。
  • Topical treatment for mastalgia
    申请人:——
    公开号:US20040018991A1
    公开(公告)日:2004-01-29
    A composition for medicinal treatment by means of topical administration is described, which contains an aromatase inhibitor, in addition to conventional constituents of topical forms of administration. The active ingredient or the composition containing this active ingredient is especially suitable for the prophylaxis and for the treatment of mastalgia.
    本文描述了一种用于局部给药的医疗治疗组合物,其中包含一种芳香化酶抑制剂,除了传统的局部给药成分之外。这种活性成分或含有该活性成分的组合物特别适用于乳房疼痛的预防和治疗。
  • Methoxylation of enolizable steroidal 4-ene-3-ones using hypervalent iodine
    作者:Mitsuteru Numazawa、Mieko Ogata
    DOI:10.1039/c39860001092
    日期:——
    Reaction of androst-4-ene-3,17-dione (1) with o-iodosylbenzoic acid in methanolic potassium hydroxide gave the methoxylated products, the 4- and 6β-methoxides (2) and (3), along with the dehydrogenated compound, the 4,6-dienone (4).
    雄烷-4-烯-3,17-二酮(1)与邻碘烷基苯甲酸在甲醇氢氧化钾中反应制得甲氧基化产物,4-和6β-甲醇盐(2)和(3)以及脱氢化合物,4,6-二烯酮(4)。
  • composition and uses for influencing hair growth
    申请人:Schmidt Alfred
    公开号:US20110117218A1
    公开(公告)日:2011-05-19
    The invention describes a combination of at least one aromatase inhibitor selected from the group of chemical-synthetic aromatase inhibitors and aromatase inhibition exhibiting extracts of soya beans and rapeseed, respectively, and at least one plant extract that contains one or more active ingredient substance(s) extracted from the plant, which is(are) selected from the group of 5α reductase type I and/or type II inhibitors and androgen receptor blockers, said combination being contained for example in a composition and having special properties for influencing hair growth. Uses of this combination are also described.
    该发明描述了一种组合物,该组合物包括至少一种从化学合成芳香化酶抑制剂和大豆和油菜籽提取物中选择的芳香化酶抑制剂和至少一种植物提取物,该植物提取物含有从植物中提取的一个或多个活性成分,所述活性成分从5α还原酶I型和/或II型抑制剂和雄激素受体阻断剂中选择,该组合物例如包含在一种组合物中,并具有影响头发生长的特殊性质。还描述了该组合物的用途。
  • Composition and uses for influencing hair growth
    申请人:S.W. Patentverwertungs Limited
    公开号:US11052059B2
    公开(公告)日:2021-07-06
    The invention describes a combination of at least one aromatase inhibitor selected from the group of chemical-synthetic aromatase inhibitors and aromatase inhibition exhibiting extracts of soya beans and rapeseed, respectively, and at least one plant extract that contains one or more active ingredient substance(s) extracted from the plant, which is(are) selected from the group of 5α reductase type I and/or type II inhibitors and androgen receptor blockers, said combination being contained for example in a composition and having special properties for influencing hair growth. Uses of this combination are also described.
    本发明描述了至少一种芳香化酶抑制剂(分别选自化学合成芳香化酶抑制剂和具有芳香化酶抑制作用的大豆和油菜籽萃取物)与至少一种植物萃取物的组合,该植物萃取物含有一种或多种从植物中提取的活性成分物质,这些活性成分物质选自 5α 还原酶 I 型和/或 II 型抑制剂以及雄激素受体阻断剂。此外,还介绍了这种组合物的用途。
查看更多